News

Zacks Investment Research on MSN21h
Merck Starts Phase III Studies on Once-Monthly Pill for HIV Prevention
Merck MRK recently launched two late-stage clinical studies to evaluate MK-8527, its investigational once-monthly oral pill for HIV pre-exposure prophylaxis (PrEP). The EXPrESSIVE-11 study, which ...
BuzzFeed on MSN1d
If You're Willing To Risk $10 Or Less, These 42 Cool Products Are Worth Taking A Chance On
It's time for you to join the ranks of the thousands of reviewers obsessed with this $7 holy grail tubing mascara and this ...